{"id":"W2967517485","doi":"10.1245/s10434-019-07685-1","title":"Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial","year":2019,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Medicine; Pancreaticoduodenectomy; Erlotinib; Gemcitabine; Surgical oncology; Internal medicine; General surgery; Adenocarcinoma; Oncology; Chemotherapy; Cancer; Pancreas","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001053085,0.001720486,0.002098691,0.0003497014,0.0003025226,0.001378286,0.0007810523,0.0009941165,0.005088214],"category_scores_gemma":[0.0008390317,0.0005111977,0.00271288,0.0003894579,0.0008888766,0.001111968,0.0005401011,0.004138716,0.001214876],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000880746,"about_ca_system_score_gemma":0.001244906,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009041521,"about_ca_topic_score_gemma":0.003928568,"domain_scores_codex":[0.9997465,0.0001045934,0.00001536981,0.0000540391,0.00001843182,0.00006097785],"domain_scores_gemma":[0.9996098,0.00006448292,0.00008627756,0.00003696644,0.0000166723,0.0001858005],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8248802,0.01409482,0.002688448,0.002694952,0.003523273,0.0001413399,0.0001526746,0.003160809,0.006838174,0.000577452,0.008033966,0.1332138],"study_design_scores_gemma":[0.8232316,0.161238,0.005867759,0.0001865764,0.00203249,0.0002151524,0.0001084777,0.001028052,0.0009767439,0.0005821233,0.00449233,0.00004058916],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9765545,0.01245229,0.0007355033,0.001653844,0.0009244438,0.001508681,0.001478219,0.000203706,0.00448879],"genre_scores_gemma":[0.9690165,0.01225633,0.001796469,0.002945794,0.0005973183,0.00218206,0.004073829,0.00006486525,0.007066959],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005088214,"threshold_uncertainty_score":0.01702178,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1237053772445335,"score_gpt":0.4462427632981852,"score_spread":0.3225373860536517,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}